Catheter Precision announced that the LockeT suture retention device has been validated for safety and efficacy in large-bore venous access closure in a study of 139 patients, published in the Journal of Interventional Cardiac Electrophysiology. The study highlights LockeT's high success rate, quick hemostasis, early patient mobility, and low complications, supporting its use in electrophysiology procedures. This peer-reviewed publication strengthens Catheter Precision's market position and aligns with its strategy to expand hospital adoption in the US and Europe. The company also recently engaged a strategic advisor to explore further growth opportunities for its electrophysiology products.
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
The global warehouse shuttle software market is projected to grow from $1.57 billion in 2026 to $2.66 billion by 2030, with a CAGR of 14.1%. Growth is fueled by rising e-commerce, warehouse automation, AI-driven orchestration, and robotic material ha...
